Financial Results for Q2 - FY2026
Filed with TSE · · 40 pages · English
Summary by 6ix AI
Nippon Shokubai Co., Ltd. has released its financial results for the second quarter of the fiscal year, covering a six-month period. The report highlights a year-on-year increase in both revenue and operating profit, driven by higher inventory valuation gains and improved performance in the Solutions business. Additionally, the company has revised its full-year forecasts upward, anticipating continued growth in revenue and profit for the fiscal year. The filing also discusses business overviews and shareholder returns, including a planned increase in dividends.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Nippon Shokubai Co., Ltd. on 6ix
Story so far
Earlier from Nippon Shokubai
- Notice Regarding Acquisition of Shares of GOO Chemical Co., Ltd. (to Make It a Subsidiary)
- Notice Regarding Purchase of Treasury Shares
- Nippon Shokubai Enters into Strategic Collaboration with PURMX Therapeutics on Drug Delivery System (DDS) Material “Fol-Dab8” -Evaluating the Potential of Combining Fol-Dab8 with Naturally Occurring microRNA for Novel Oligonucleotide Therapeutics-
- Notice Concerning Partial Changes to the Construction Plan of a New Plant for LiFSI (IONEL), an Electrolyte for Lithium-ion Batteries
- Consolidated Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2027 [IFRS]
Follow Nippon Shokubai into a list and get an email when it puts out news.
Follow Nippon Shokubai